Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1535, 2006-01, pp. : 13-13
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Amfebutamone for second-line treatment only
Inpharma, Vol. 1, Iss. 1309, 2001-01 ,pp. :
Access to resources
Recommend
Second-line drug therapy for osteoarthritis
Clinical Medicine, Vol. 1, Iss. 2, 2001-03 ,pp. :
Lenalidomide plus dexamethasone a winner as second-line therapy
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 645, 2012-01 ,pp. :
Gefitinib promising as second-line therapy for oesophageal cancer
Inpharma, Vol. 1, Iss. 1469, 2005-01 ,pp. :
Second-line pemetrexed, docetaxel similarly effective for NSCLC
Inpharma, Vol. 1, Iss. 1439, 2004-01 ,pp. :